Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control

Summary

Saxagliptin is a new investigational medication being developed for treatment of type 2 diabetes. This study is designed to evaluate the efficacy and safety in adult patients with inadequate glycaemic control with diet and exercise.

Timeline

Start

2008-06

Primary completion

2009-10

Completion

2009-10

Outcome

Met primary endpoint

registry analysis (superiority or other test); Saxagliptin 5 mg vs Placebo; p <0.0001; Mean Difference (Net) -0.50 (95% CI -0.65 to -0.34); ANCOVA NCT00698932 ↗

Publications

• Perl S, Cook W, Wei C, Iqbal N, Hirshberg B. Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment. Diabetes Ther. 2016 Sep;7(3):527-35. doi: 10.1007/s13300-016-0184-9. Epub 2016 Jul 11.

Drugs

Indications